Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
Veronika Whitesell SkrivankovaJacqueline HuwaGuy MuulaGeldert D ChiwayaEsau BandaShameem BuleyaBelinda ChihotaJoseph ChintedzaCarolyn BoltonHannock TweyaThokozani KaluaStefanie HossmannRoger KouyosGilles WandelerMatthias EggerRichard J LessellsPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Clinicaltrials.gov (NCT04612452).